Analysis of CSF proteins is useful in the diagnosis and management of neurological diseases in the following situations:
I. In inflammatory conditions when there is breakdown of blood-CSF barrier integrity. Meningitis is a medical emergency, with CSF total protein measurement being only a screening test.
2. In the detection of immune responses within the CNS. This is by far the most important application in a routine clinical setting, as it is now a firmly established criterion in the diagnosis of multiple sclerosis. Oligoclonal bands restricted to the CSF are the only reliable indicators of intrathecal immunoglobulin G synthesis and are practically always associated with inflammatory disease of the CNS. The method of choice for detecting oligoclonal bands is isoelectric focusing with immunofixation. Quantitative measurement of IgG in the CSF is of no value in diagnostic pathology.
3. In destructive brain diseases when brain-specific proteins are released into the CSF, measurement of these proteins can give prognostic information.
Additional key phrases: oligoclonal banding; neurological diseases; multiple sclerosis Some 80% of the total protein in the cerebrospinal fluid (CSF) consists of plasma proteins which have transferred across the combined blood-CSF barriers. The remainder is derived from proteins which are synthesized within the central nervous system (CNS). In normal adult CSF, all of the albumin and immunoglobulins are derived from the plasma. In inflammatory conditions, however, migration of lymphocytes into the CNS tissues results in synthesis and release of immunoglobulins into the extracellular space and subsequently the CSF. Such 'locally synthesized' immunoglobulins are important markers of inflammatory conditions and will be dealt with more comprehensively later. Studies on proteins in the CSF can be used in three circumstances: I. To assess blood-CSF barrier function, when an increase in the CSF total protein level will result from increased leakage of plasma proteins across impaired barriers;
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Correspondence: Dr E J Thompson. 2. In the detection of inflammatory conditions involving the humoral immune system, when there is intrathecal synthesis of immunoglobulins;
3. As a measure ofCNS destruction, when brainspecific proteins will be released.
In many diseases two or all of these may occur concurrently.
Discussions on the role of brain-specific proteins in pathological conditions are beyond the scope of this paper. Further information is available from recent reviews.l-' These assays are of limited value in differential diagnosis but can have some prognostic value.
To appreciate the application of CSF protein analysis in the other two circumstances it is necessary to understand the general mechanisms governing protein entry into the CSF.
FORMATION OF CSF AND THE DISTRIBUTION OF PROTEINS ALONG THE CSF SPACE
CSF is produced at a rate of some 500 mL/day3.4 and occupies a volume of about 135mL in the normal adult. Consequently, the CSF has an average turnover time of 6 h (24 h x 135/500). The circulation of the CSF within the cranium is more rapid than that within the spinal canal and lumbar CSF has an equilibrium time for radiolabelled albumin of 2-4 days.s. 6 Approximately two-thirds of the total volume of CSF is produced by the choroid plexuses" which lie in the lateral ventricles. The remainder is produced at extrachoroidal sites.l" Most arises from fluid shifts across various vascular beds such as the cerebral capillaries, and the dorsal root ganglia, which show a relatively greater leakage of plasma proteins. 10 Finally a small proportion, possibly up to 15% of the fluid, may be produced as the endpoint of the metabolism of glucose" upon which the brain is normally totally dependent to supply its energy needs. This latter source is unique in that it is a source of pure, locally synthesized water.
It can be shown that four factors influence the final CSF concentration of proteins originating in the plasma:
1. The molecular radius of the protein-the larger the molecule the lower the CSF concentration because of the filtering effect of the barriers; II 2. The charge on the molecule--ehemically altering the ionic charge on a protein influences its percentage transfer;"
3. The plasma concentration-in general the CSF concentration of a protein is proportional to that in the plasma; 13 4. The functional state of the blood-CSF barriers -if the barriers are impaired, proteins will leak from the plasma into the CSF. 14 Of these factors, 1 and 2 are physiocochemical constants and are unlikely to be influenced by pathology, with the possible exception of charge isomers resulting from, e.g. enzyme-induced changes in molecules. Factors 3 and 4 are influenced by physiological and pathological changes.
Passive filtration appears to be the dominant mechanism governing transfer of proteins across the various blood-CSF barriers. All plasma proteins commonly measured have been identified in CSF, demonstrating the lack of an upper limit for molecular size exclusion by the blood-CSF barriers Some proteins may also be transferred through the action of specific receptors. For example, receptors for transferrin have been demonstrated on the lumenal surface of cerebral capillaries. IS Transferrin forms complexes with these receptors and after internalization and removal of iron, the transferrin is then released from the cell. Some transferrin is released to the cerebral side of the barrier. If during the intracellular phase transferrin loses terminal sialic acid residues from the carbohydrate side chain, then this mechanism may explain the presence of tau protein in CSF . 16 Tau protein is a desialated transferrin present in significant amounts in CSF but essentially absent from blood because of its rapid removal by asialoreceptors present on reticuloendothelial cells. Tau protein is clearly identified by polyacrylamide gel electrophoresis and increased proportions of tau relative to transferrin can be seen when there is release of lysosomal hydrolases into CSF due to cell death. This may be enhanced if there is also a reduction in CSF flow, as seen for example in vertebral disc protrusion." Transferrin may also be locally synthesized within the CNS. Messenger RNA coding for transferrin has been identified in choroid epithelial cells." Diseases which affect CSF flow do not necessarily affect the permeability of the blood-CSF barriers and vice versa.
Increased passage of plasma proteins into the CSF occurs in many CNS disorders. Most commonly this results from direct damage to the barriers, so the term barrier impairment is widely used, although it should be appreciated that in some instances obstructed flow may be contributory or the sole cause. Such alterations can be detected by total protein estimation, specific protein assays" or by electrophoresis, either in polyacrylamide gd 4 • 25 (PAGE) or agarose." Some acute neurological conditions, such as bacterial meningitis, are life threatening and rapid diagnosis is essential. In such cases laboratory results must always be rapidly available. The measurement of CSF total protein is considered to be of value when patients present with acute Under normal circumstances most of the CSF travels up over the cerebral cortex to be reabsorbed, rather than down into the cul-de-sac of the spinal canal where flow is slower. In patients who are immobilized in bed, the lumbar CSF total protein may be increased because of reduced flow of fluid down the spinal canal, which allows increased equilibration with Values are mean (standard deviation). plasma.
Data from references 29 and 30. Within the brain parenchyma there is no restriction to the movement of proteins between the extracellular fluid compartment and the CSF. The combined effect of the barriers is to maintain the CSF total protein at approximately 1/350 that of the plasma.
CSF barriers are less selective for the passage of proteinsthan renal barriers ( Fig. I) . Lumbar CSF has a total protein concentration which is three times as great as fluid sampled from the ventricles" and the protein composition of the mixture is also different for the two fluids, the ventricular fluid having a higher proportion of low molecular weight proteins than lumbar fluid. This is due to progressive equilibration of CSF with plasma through the capillary walls during passage down the spinal canal. The selectivity of the barriers for albumin and IgG is, however, the same."
Prealbumin is synthesized by the choroidal epithelium. I? The concentration of prealbumin is the same in ventricular and lumbar fluids," although as a proportion of the total protein there is more prealbumin in ventricular than lumbar fluid. Prealbumin is a useful marker for deciding whether a watery nasal discharge is CSF. A high prealbumin as a proportion of total protein favours CSF, whilst a low proportion of prealbumin suggests a non-cranial source for the fluid. A similar differentiation is possible using tau protein.
Bulk resorption of CSF occurs at the arachnoid granulations of Pacchioni in the superior sagittal sinus. There is no size dependence for the movement of fluid or solutes from the thecal space back into the blood."
Mixing of the CSF during its circulation is achieved by: (Table I ). In acute conditions however, the most helpful tests are a CSF differential cell count,":" and measurement of serum C-reactive protein." The role of CSF C-reactive protein is controversial.l'-" CSF lactate is increased in cerebrovascular disease and brain tumours as well as in bacterial meningitis. However, a CSF lactate greater than 3·5 mmol/L with a CSF cell count above 800/jJL allows the diagnosis of bacterial meningitis to be made with a high degree of reliability." CSF lactate is normal in viral meningitis." These tests should be available in all routine laboratories dealing with neurological patients.
Determination of albumin is a better marker of barrier function than that of total protein." Because of improved analytical precision, the replacement of CSF total protein by albumin is advised where possible. Measuring either CSF total protein or albumin is of limited value in the differential diagnosis of acute neurological conditions. Exceptions include acute Guillain-Barre syndrome, which is characterized by an increased total protein but a normal CSF white cell count, so called 'la dissociation albumino-cytologique'. Alpha-2 macroglobulin may have advantages in assessing barrier state,23.38,39 but this is disputed by others."
A low lumbar CSF prealbumin concentration as a proportion of the total protein is consistent with obstructed flow within the spinal canal.
It is important to realise that the application of more sensitive methods such as PAGE to the study of CSF proteins enables identification of impaired barrier function or CSF flow problems when the CSF total protein is still within the reference range for that age group. This is however, a specialized test.
CSF IMMUNOGLOBULINS: THE STUDY OF TOTAL AND FRACTIONATED GAMMA-GLOBULINS
Intrathecal synthesis of immunoglobulins can be studied by quantitative and qualitative means.
Quantitative immunoglobulin abnormalities A quantitative increase in CSF immunoglobulin concentration can arise from three causes:
1. Secondary to an increase in plasma immunoglobulin level;
2. As a result of blood-CSF barrier impairment; and 3. Directly from local synthesis.
Local synthesis can occur in many diseases affecting the CNS including chronic infections by micro-organisms, primary demyelinating diseases, such as multiple sclerosis (MS), and auto-immune conditions such as Bechet's disease and neurosarcoidosis.
In order to distinguish true intrathecal synthesis from the other two situations it is necessary to correct the measured immunoglobulin concentration by the expected contribution of the first two factors. Correcting for plasma concentration is done simply by calculating the CSF/serum concentration ratio for the immunoglobulin.
To correct for barrier function it is necessary to measure a reference protein whose behaviour at the blood-CSF barriers is similar to that of the immunoglobulin. Albumin is widely used for this purpose.t'<" although oc-2 rnacroglobulirr'v" and haptoglobin" have also been used. If the barrier is impaired then there will be a proportional leak of albumin into the CSF along with immunoglobulin. Thus dividing the CSFIserum ratio for immunoglobulin by the CSF/serum ratio for albumin, corrects the CSF immunoglobulin concentration for both serum immunoglobulin concentration and blood-CSF barrier function at the same time:
CSF Ig x serum albumin serum Ig x CSF albumin This quotient, the immunoglobulin index, was originally developed by Delpech and Lichtblau" who plotted the ratio of CSF IgG to albumin against the same ratio in serum. A different graphical, although mathematically equivalent, plot of the CSF/serum ratio for IgG against that for albumin was used by Ganrot and Laurell" and is currently employed by the SAS laboratories." whilst alternative formulae are also applied. 47 5 1 In the detection of intrathecal sythesis of IgG quantitative measurements have now proved much less useful than the detection of oligoclonal bands. The IgG index will identify only 58% of patients showing positive oligoclonal. bands by isoelectric focusing." Therefore quantitative measurements should be discontinued for diagnostic purposes.
Qualitative immunoglobulin abnormalities
In addition to quantitative changes, locally synthesized IgG also demonstrates qualitative differences from normal. These immunoglobulins manifest themselves as discrete bands against the polyclonal background. As these bands are thought to represent the products of a limited number of clones of plasma cells, the pattern is referred to as oligoclonal. This is distinct from the polyclonal background which is the product of a very large number of plasma cell clones secreting immunoglobulins. When a clone has an adequate number of cells secreting immunoglobulin this clonal product becomes detectable against the background. The normal amount of background polyclonal IgG is relatively low in CSF as all of the y-globulins are derived from serum. so locally synthesized clonal products are readily visible at very low concentrations. Oligoclonal banding is without doubt the best method for detecting intrathecal synthesis of immunoglobulins. 5257
Oligoclonal immunoglobulin bands can only be demonstrated by qualitative methods. Most commonly these are electrophoresis in agar,58.59 agarose.f'" cellulose acetate 62.6J or polyacrylamide gel"" and isoelectric focusing in either polyacrylamide gel59.60.65.66 or agarose/"" Electrophoretic methods that use a general protein stain after separation can pose problems of interpretation. There are two CSF-'specific' proteins which may be detected upon electrophoresis. namely fJ-trace and y-trace. These can be confused with oligoclonal bands. Beta-trace protein is synthesized within the CNS. has no known physiological function and
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migrates in the fJ-region as a single band on non-sieving media or as four bands on polyacrylamide gels." Gamma-trace is a low molecular weight cysteine proteinase inhibitor of the cystatin family which is also synthesized within the CNS. 7l • n In non-sieving media it migrates in the slow-y, As it has a pI of9·2 y-trace does not enter the gel in most polyacrylamide gel systems. The mobility of both fJand y-trace proteins change on storage," and old samples may show ,'-trace anywhere in the I' region. To avoid these interpretative difficulties immunofixation techniques must be used to identify true oligoclonal bands. Although usually considered to be CSF-specific, both of these proteins can be detected in plasma using immunochemical methods.
Methods vary in their sensitivity for detecting oligoclonal bands. Workers using isoelectric focusing (IEF) are almost unanimous in finding that this is the most sensitive method.52.55.57.7J As with most qualitative methods. artefacts are easily recognized by separating a matched serum in parallel. We advocate focusing in agarose followed by nitrocellulose blotting and immunefixation (IF) with enzyme-labelled antiserum," as this enables studies to be carried out on 5ilL of unconcentrated CSF or less. Techniques which do not include an immunofixation step must not be used: methods involving isoelectric focusing and immunofixation after prior concentration of CSF detected only 86% of cases which were positive using unconcentrated CSF. Oligoclonal bands may be observed in CSF and sometimes in serum. It is imperative that both CSF and serum are studied in parallel. Using this approach the following patterns may be found (Fig. 2) I. Bands present in CSF but absent from corresponding serum. This is consistent with an immune response restricted to the CNS. This pattern is typically found in multiple sclerosis.
2. Identical patterns of bands in both CSF and serum. This suggests that the CSF is reflecting a serum abnormality with transfer of abnormal immunoglobulins across the blood-CSF barriers. This pattern is seen in paraproteinaemia and in systemic infections.
Bands present in both CSF and serum, but
with the CSF having additional components which are not present in the serum. This is found in conditions where there is systemic pathology but with an additional neurological component. An example is subacute sclerosing panencephalitis (SSPE). In this condition the humoral immune response to the virus occurs outside the CNS, but because there is also growth of the virus within the brain, there is an additional antibody response within the CNS.
By studying CSF and serum in parallel, evidence can be obtained of whether the disease is CNS-specific, systemic or systemic with neurological involvement as an additional feature, e.g. in neurosarcoidosis or neurosyphilis.
It is important to note that oligoclonal bands are not synonymous with local synthesis. Oligoclonal bands must be demonstrated to be unique to the CSF before the term 'locally synthesized' can be applied.
The influence of the blood-CSF barriers should always be taken into account when looking for oligoclonal bands. In the presence of overt barrier damage locally synthesised oligoclonal bands may be completely eclipsed by transudated polyclonal plasma immunoglobulins." Such obscuring effects may occur in cases of Guillain-Barre syndrome and in some cases of severe bacterial meningitis. In MS the CSF total protein is not usually increased, and values greater than 1000 mg/L make this diagnosis unlikely. It must be emphasized at this point that oligoclonal bands should not be thought of as a pathognomonic test for multiple sclerosis. The presence of oligoclonal bands always indicates an immune response which must be further investigated. When all alternative causes have been excluded, it is then possible to make a confident diagnosis of MS (see below).
It is generally accepted that oligoclonal bands are the products of clones of lymphocytes resident within the CNS and which have migrated into the brain from the peripheral circulation. It has been estimated that in MS the brain may contain up to 10 8 plasma cells sequestered in the tissue, with a total synthetic capacity for IgG of up to IOOmg/day. IgG extracted from brain tissue has an oligoclonal IgG pattern." Lymphocytes isolated from the CSF of patients with MS synthesise oligoclonaI IgG in vitro," In MS the oligocional pattern is unique to each patient." There is no correlation between the distribution of the bands in the oligoclonal pattern and any particular disease, with the exception of the paraproteinaemias where the band pattern is clearly due to differences in the charge within the monoclonal protein.
In MS, the pattern of the oligoclonal bands shown by IEF has been shown to vary from plaque to plaque." implying that each plaque attracts unique lymphocytes. This is in contrast to the situation found in SSPE, which is also associated with demyelination, in which the distribution of bands in the oligoclonal pattern is similar between different plaques."
In MS the oligoclonal band pattern may remain remarkably constant over long periods." Thompson et al., however, found sequential changes in pattern in 12/25 patients with a remitting .relapsing course." A pattern which changes with time is also found in SSPE. 7Y Longitudinal studies have shown that patients with monosymptomatic presentation consistent with MS have a significantly increased risk of developing clinically definite MS if they have oligoclonal bands at initial presentation. 8°-82 The absence of oligoclonal bands in a patient suspected of having MS casts doubt on the diagnosis and an alternative cause for the symptoms should be considered."
Although. most of the work concerning oligoclonal bands has been done on IgG, IgM can also have an oligoclonal distribution.t':" Indeed there are good reasons why oligoclonal IgM should be studied in preference, to IgG. In the ontogeny of the immune response it is well recognized that IgM responds much earlier in the development of antibody production, about 5-7 days which should be contrasted to the 10-15 days which is typical of the time required to generate oligoclonal IgG bands, thus limiting the value of IgG studies in acute conditions. Also, during therapy of neurosyphilis it has been This is not a comprehensive list but contains the more common conditions associated with oligoclonal bands. The values quoted for the incidence of oligoclonal bands in these conditions are taken from the literature, but may have been obtained on small numbers of cases and often using insensitive methods. Modified from reference 16. shown that successful treatment of the treponemaI infection leads to the disappearance of oligoclonal IgM over 2-3 months, followed by a more gradual loss over several years (if at all) of the oligoclonal IgG pattern." This slow decay of IgG after removal of antigenic challenge limits the value of IgG studies in assessing response to therapy, whereas ifIgM oligoclonal bands persist it implies a failure of therapy. Oligoclonal bands consisting of free light chains are also documented.V?" In MS high free kappa and free lambda chain levels and indices, calculated as for IgG index, are associated with either the presence of oligoclonal bands, or a high IgG index." Fagnart et al," found increased free light chains in 85% of cases of MS, an incidence which is the same as for oligoclonal bands in their study. In contrast the IgG index was increased in only 66% of the same population. Local synthesis of free lambda light chains has also been seen in viral infections 88 • 89 and SSPE. 87 Increased free kappa chain levels have been seen in viral encephalitis and meningoradiculitis due to Borrelia burgdorfer]" infection. Both these infections are characterized by a strong immune response within the CNS. Viral meningitis shows only a low incidence of free light chain production." Free light chains may be present when tests for oligoclonal IgG are negative.":"
There are two applications for laboratory tests, aiding diagnosis and monitoring therapy or disease progression. The former has a greater requirement for methods which are sensitive and specific, whilst the latter require methods which are accurate and precise. Thus, to assist diagnosis oligoclonal bands must be looked for. Numerically the most important of the inflammatory conditions affecting the CNS is MS. The literature shows that quantitative measurement of IgG is of limited value in monitoring the progression of MS. 9J -95 In contrast, the presence of oligoclonal IgG bands is now an accepted criterion in the classification of MS 96 which means that laboratory tests are now an important factor in achieving the correct diagnosis. This is particularly true for patients who are monosymptomatic and in whom other laboratory tests may be normal. Oligoclonal bands should not be thought of as a simple test for MS however, and alternative inflammatory conditions must be excluded first (see Table 2 ). 
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